Marker Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $1,232 | $861 | $349 | $2,251 |
Gross Profit | 1,232 | -3,315 | -2,786 | -2,834 |
EBITDA | -1,998 | -4,261 | -4,446 | -3,861 |
EBIT | -1,998 | -4,261 | -8,602 | -3,861 |
Net Income | -1,998 | -4,015 | -4,446 | -3,837 |
Net Change In Cash | 1,232 | 861 | 349 | 2,251 |
Free Cash Flow | -2,735 | -1,878 | -5,499 | -4,703 |
Cash | 17,589 | 10,461 | 13,693 | 19,192 |
Basic Shares | 16,757 | 13,956 | 11,106 | 9,101 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $6,591 | $3,311 | $3,513 | $1,241 |
Gross Profit | -6,876 | -7,105 | -8,454 | -1,920 |
EBITDA | -11,118 | -11,792 | -17,001 | -38,716 |
EBIT | -11,118 | -14,581 | -19,791 | -41,878 |
Net Income | -10,731 | -8,236 | -29,930 | -41,878 |
Net Change In Cash | 6,591 | 3,311 | 3,513 | 1,241 |
Free Cash Flow | -10,910 | -16,439 | -26,972 | -30,410 |
Cash | 19,192 | 15,111 | 11,782 | 42,351 |
Basic Shares | 8,980 | 8,809 | 8,351 | 7,651 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.12 |
2025-06-30 | -$0.29 |
2025-03-31 | -$0.42 |
2024-12-31 | -$0.42 |
